scholarly journals Expansion of the Multi-Link Frontier™ Coronary Bifurcation Stent: Micro-Computed Tomographic Assessment in Human Autopsy and Porcine Heart Samples

PLoS ONE ◽  
2011 ◽  
Vol 6 (7) ◽  
pp. e21778 ◽  
Author(s):  
Stefan Kralev ◽  
Benjamin Haag ◽  
Jens Spannenberger ◽  
Siegfried Lang ◽  
Marc A. Brockmann ◽  
...  
Heart ◽  
2014 ◽  
Vol 100 (6) ◽  
pp. 479-486 ◽  
Author(s):  
Maik J Grundeken ◽  
Maciej Lesiak ◽  
Solomon Asgedom ◽  
Eulogio Garcia ◽  
Armando Bethencourt ◽  
...  

2010 ◽  
Vol 55 (10) ◽  
pp. A199.E1873 ◽  
Author(s):  
Kenji Sakata ◽  
Bon-Kwon Koo ◽  
Daisaku Nakatani ◽  
Katsuhisa Waseda ◽  
Junya Ako ◽  
...  

2021 ◽  
Vol 78 (19) ◽  
pp. B41
Author(s):  
Yusuke Watanabe ◽  
Masahiro Yamawaki ◽  
Junya Shite ◽  
Kinoshita Yoshihisa ◽  
Munenori Okubo ◽  
...  

2020 ◽  
Vol 16 (5) ◽  
pp. 397-404
Author(s):  
Dobrin Iotkov Vassilev ◽  
Niya Boykova Mileva ◽  
Robert J Gill

The bifurcation optimization stent system (BiOSS) LIM (Balton, Warsaw, Poland) stent is a dedicated coronary bifurcation stent. Its unique construction is developed in accordance with the anatomy of the coronary bifurcations, thus eliminating the carina displacement as a mechanism of side branch ostium compromise. Since its development in 2008, the BiOSS stent underwent several changes with the latest version created of sirolimus eluting cobalt-chromium stent. Results from registries and randomized clinical trials showed that implantation of the BiOSS stent is safe and effective with comparable results for major adverse cardiovascular events (MACE) and target lesion revascularisation rates between the BiOSS and regular drug-eluting stent groups. This stent provides alternative for coronary bifurcation treatment, especially when there is a large difference in diameter between the main vessel and the main branch.


Sign in / Sign up

Export Citation Format

Share Document